Opexa Therapeutics: Corporate Presentation (Opexa Therapeutics) - May 15, 2015 - “Reversal of Disability in Prospective Analysis in More Active Patients”; “Sub-population of patients (n=50) with more progressed/active disease profile (baseline ARR > 1)"
P2b data • Multiple Sclerosis
|